This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stark, C A Articles by Nord, C E Search for Related Content PubMed PubMed Citation Articles by Stark, C A Articles by Nord, C E

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1993 August; 37(8): 1665-1669

Antimicrobial resistance in human oral and intestinal anaerobic microfloras.

C A Stark, C Edlund, S Sjöstedt, G Kristensen and C E Nord

Department of Microbiology, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.

ABSTRACT

In the present study we determined the resistance patterns of anaerobic bacteria from human saliva and stool specimens and investigated whether there were significant differences in resistance between outpatients and hospitalized patients, regardless of whether they had received antimicrobial agents. No bacterial strains resistant to ampicillin, piperacillin, cefoxitin, cefuroxime, imipenem, clindamycin, doxycycline, chloramphenicol, or metronidazole were isolated from the saliva samples. However, resistance to ampicillin, cefoxitin, and cefuroxime was found in strains from 70% of the fecal samples (mainly Bacteroides thetaiotaomicron, Clostridium innocuum, and Bacteroides ovatus). Resistance to both ampicillin and cefuroxime was frequently found in 19% of the isolated strains (mainly B. thetaiotaomicron, B. ovatus, and Bacteroides vulgatus). No strains that were resistant to imipenem, chloramphenicol, or metronidazole were found. Hospitalization and/or intake of antimicrobial agents was associated with an increase in the relative number of resistant anaerobic intestinal bacteria. The percentage of resistant anaerobic strains encountered, compared with the total number of anaerobic bacteria in the normal fecal microflora, was between 5.2 and 14.8%, with the lower value associated with the outpatient group. Two-thirds of the resistant strains from this group had a relative frequency of less than 1% of the total anaerobic flora, while one-third of the strains were present at a level of greater than 1%; for the hospitalized patients, two-thirds of the strains were present at a level of greater than 1%, and one-third of the strains were present at a level of less than 1% (P < 0.001). Patients who had received antimicrobial agents for 6 days or more (n=20) had an average of 1.6 resistant anaerobic strains each, while patients treated for 3 to 5 days (n = 30) had a mean number of 0.87 resistant strains each ( P < 0.05).

---

Antimicrob Agents Chemother. 1993 August; 37(8): 1665-1669

This article has been cited by other articles:

• Tarkkanen, A.-M., Heinonen, T., Jogi, R., Mentula, S., van der Rest, M. E., Donskey, C. J., Kemppainen, T., Gurbanov, K., Nord, C. E. (2009). P1A Recombinant {beta}-Lactamase Prevents Emergence of Antimicrobial Resistance in Gut Microflora of Healthy Subjects during Intravenous Administration of Ampicillin. Antimicrob. Agents Chemother. 53: 2455-2462 [Abstract] [Full Text]  
• Harmoinen, J., Mentula, S., Heikkila, M., van der Rest, M., Rajala-Schultz, P. J., Donskey, C. J., Frias, R., Koski, P., Wickstrand, N., Jousimies-Somer, H., Westermarck, E., Lindevall, K. (2004). Orally Administered Targeted Recombinant Beta-Lactamase Prevents Ampicillin-Induced Selective Pressure on the Gut Microbiota: a Novel Approach to Reducing Antimicrobial Resistance. Antimicrob. Agents Chemother. 48: 75-79 [Abstract] [Full Text]  
• Hecht, D. W., Osmolski, J. R. (2003). Activities of Garenoxacin (BMS-284756) and Other Agents against Anaerobic Clinical Isolates. Antimicrob. Agents Chemother. 47: 910-916 [Abstract] [Full Text]  
• Nyfors, S., Kononen, E., Syrjanen, R., Komulainen, E., Jousimies-Somer, H. (2003). Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood. J Antimicrob Chemother 51: 107-112 [Abstract] [Full Text]